References
- Singletary K. Black pepper: overview of health benefits. Nutr Today 2010;45:43–7
- Srinivasan K. Black pepper and its pungent principle-piperine: a review of diverse physiological effects. Crit Rev Food Sci Nutr 2007;47:735–48
- Khan IA, Mirza ZM, Kumar A, et al. Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus. Antimicrob Agents Chemother 2006;50:810–12
- Poole K. Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 2005;56:20–51
- Maltezou HC, Giamarellou H. Community-acquired methicillin-resistant Staphylococcus aureus infections. Int J Antimicrob Agents 2006;27:87–96
- Chambers HF, DeLeo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009;7:629–41
- Hermsen ED, Dandekar PK, Nightingale CH. Methicillin-resistant S. aureus: a pathogen transitioning from the hospital to the community. J Infect Dis Pharmacother 2003;6:39–57
- Rehm SJ, Tice A. Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus. Clin Infect Dis 2010;51:S176–82
- Greenlaw CW, Ott FB. Successful treatment of apparent methicillin-resistant S. aureus endocarditis with gentamicin and cephalothin. Drug Intell Clin Pharm 1979;13:150–4
- Milatovic D. Vancomycin for treatment of infections with methicillin-resistant Staphylococcus aureus: are there alternatives? Eur J Clin Microbiol Infect Dis 1986;5:689–92
- Mun S-H, Joung D-K, Kim Y-S, et al. Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus. Phytomedicine 2013;15:714–18
- Liu PF, Lo CW, Chen CH, et al. Use of nanoparticles as therapy for methicillin-resistant Staphylococcus aureus infections. Curr Drug Metab 2009;10:875–84
- Meng J, Wang H, Hou Z, et al. Novel anion liposome-encapsulated antisense oligonucleotide restores susceptibility of methicillin-resistant Staphylococcus aureus and rescues mice from lethal sepsis by targeting mecA. Antimicrob Agents Chemother 2009;53:2871–8
- Chowdhury M, Goswami R, Chakrabarti P. Liposome‐trapped penicillins in growth inhibition of some penicillin‐resistant bacteria. J Appl Microbiol 1981;51:223–7
- Swenson CE, Popescu MC, Ginsberg RS, Juliano RL. Preparation and use of liposomes in the treatment of microbial infections. Crit Rev Microbiol 1988;15:S1–31
- Moghadas-Sharif N, Fazly Bazzaz BS, Khameneh B, Malaekeh-Nikouei B. The effect of nanoliposomal formulations on Staphylococcus epidermidis biofilm. Drug Dev Ind Pharm 2014. [Epub ahead of print]. doi:10.3109/03639045.2013.877483
- Liu P-F, Lo C-W, Chen C-H, et al. Use of nanoparticles as therapy for methicillin-resistant Staphylococcus aureus infections. Curr Drug Metab 2009;10:875–84
- NCCLS, in methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically M7-A5. National Committee on Clinical Laboratory Standards 2000;20:2
- Botelho MG. Fractional inhibitory concentration index of combinations of antibacterial agents against cariogenic organisms. J Dent 2000;28:565–70
- Demirbilek M, Arslan H, Karaman SÖ. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Int J Antimicrob Agents 2006;27:224–8
- Pacifici GM. Clinical pharmacokinetics of penicillins, cephalosporins and aminoglycosides in the neonate: a review. Pharmaceuticals 2010;3:2568–91
- Tafaghodi M, Jaafari M-R, Sajadi Tabassi SA. Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN. Eur J Pharm Biopharm 2006;64:138–45
- Tafaghodi M, Jaafari M, Sajadi Tabassi S. Nasal immunization studies by cationic, fusogenic and cationic-fusogenic liposomes encapsulated with tetanus toxoid. Curr Drug Deliv 2008;5:108–13
- Adosraku RK, Kyekyeku JO, Attah IY. Characterization and HPLC quantification of piperine isolated from Piper guineense (fam. Piperaceae). Int J Pharm Pharm Sci 2013;5:252–6
- Bazzaz BSF, Memariani Z, Khashiarmanesh Z, et al. Effect of galbanic acid, a sesquiterpene coumarin from Ferula szowitsiana, as an inhibitor of efflux mechanism in resistant clinical isolates of Staphylococcus aureus. Braz J Microbiol 2010;41:574–80
- Mirza ZM, Kumar A, Kalia NP, et al. Piperine as an inhibitor of the MdeA efflux pump of Staphylococcus aureus. J Med Microbiol 2011;60:1472–8
- Embleton ML, Nair SP, Heywood W, et al. Development of a novel targeting system for lethal photosensitization of antibiotic-resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother 2005;49:3690–6
- Omri A, Ravaoarinoro M. Preparation, properties and the effects of amikacin, netilmicin and tobramycin in free and liposomal formulations on Gram-negative and Gram-positive bacteria. Int J Antimicrob Agents 1996;7:9–14
- Zadi B, Gregoriadis G. A novel method for high-yield entrapment of solutes into small liposomes. J Liposome Res 2000;10:73–80
- Mugabe C, Halwani M, Azghani AO, et al. Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2006;50:2016–22
- Khameneh B, Momen-nejad M, Tafaghodi M. In vivo evaluation of mucoadhesive properties of nanoliposomal formulations upon coating with trimethylchitosan polymer. Nanomed J 2014;3:147–54
- Kumar A, Khan IA, Koul S, et al. Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus. J Antimicrob Chemother 2008;61:1270–6